The regulatory mechanism by which interleukin-6 stimulates GH-gene expression in rat GH3 cells

J Endocrinol. 2006 Aug;190(2):397-406. doi: 10.1677/joe.1.06736.

Abstract

The present study was performed to elucidate the effect of interleukin (IL)-6 on the human GH (hGH)-gene expression in GH3 rat pituitary tumor cells using stable transfection of the hGH promoter fused to a luciferase reporter gene. Our results showed that IL-6 (10(2)-10(4) U/ml) stimulated GH secretion and synthesis, and promoted the luciferase expression in stably transfected GH3 cells with the maximal action of 1.99 times above the control by 10(4) U/ml IL-6. Among the inhibitors of signaling transduction pathways, mitogen-activated protein kinase kinase (MAPKK/MEK) inhibitor PD98059 (40 microM) and p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580 (5 microM) completely blocked the stimulatory effect of IL-6. Western blot analysis demonstrated that IL-6 indeed increased the activation of phosphorylated MEK and p38 MAPK in GH3 cells. Neither overexpression of Pit-1 nor inhibiting Pit-1 expression affected IL-6 induction of hGH-promoter activity. To identify the DNA sequence that mediated the effect of IL-6, six deletion constructs of hGH promoter were created. The stimulatory effect of IL-6 was abolished following deletion of the -196 to -132 bp fragment. In conclusion, our data show that IL-6 promotes GH secretion and synthesis by rat pituitary GH3 cells. The stimulatory effect of IL-6 on hGH-gene promoter appears to require the activation of MEK and p38 MAPK, and a fragment of promoter sequence that spans the -196 to -132 bp of the gene, but may be unrelated to Pit-1 protein.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Chromones / pharmacology
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Flavonoids / pharmacology
  • Gene Expression Regulation, Neoplastic*
  • Growth Hormone / genetics*
  • Imidazoles / pharmacology
  • Indoles / pharmacology
  • Interleukin-6 / physiology*
  • Maleimides / pharmacology
  • Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
  • Morpholines / pharmacology
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase C / antagonists & inhibitors
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyridines / pharmacology
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription Factor Pit-1 / genetics
  • Transcription Factor Pit-1 / metabolism
  • Transfection / methods
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors

Substances

  • Chromones
  • Flavonoids
  • Imidazoles
  • Indoles
  • Interleukin-6
  • Maleimides
  • Morpholines
  • Phosphoinositide-3 Kinase Inhibitors
  • Pyridines
  • Transcription Factor Pit-1
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Growth Hormone
  • Protein-Tyrosine Kinases
  • Cyclic AMP-Dependent Protein Kinases
  • Protein Kinase C
  • p38 Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinase Kinases
  • bisindolylmaleimide
  • SB 203580
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one